Hereditary spastic paraplegia caused by mutations in the SPG4 gene
- PMID: 11039577
- DOI: 10.1038/sj.ejhg.5200528
Hereditary spastic paraplegia caused by mutations in the SPG4 gene
Abstract
Autosomal dominant hereditary spastic paraplegia (AD-HSP) is a genetically heterogeneous neurodegenerative disorder characterised by progressive spasticity of the lower limbs. The SPG4 locus at 2p21-p22 accounts for 40-50% of all AD-HSP families. The SPG4 gene was recently identified. It is ubiquitously expressed in adult and foetal tissues and encodes spastin, an ATPase of the AAA family. We have now identified four novel SPG4 mutations in German AD-HSP families, including one large family for which anticipation had been proposed. Mutations include one frame-shift and one missense mutation, both affecting the Walker motif B. Two further mutations affect two donor splice sites in introns 12 and 16, respectively. RT-PCR analysis of both donor splice site mutations revealed exon skipping and reduced stability of aberrantly spliced SPG4 mRNA. All mutations are predicted to cause loss of functional protein. In conclusion, we confirm in German families that SPG4 mutations cause AD-HSP. Our data suggest that SPG4 mutations exert their dominant effect not by gain of function but by haploinsufficiency. If a threshold level of spastin were critical for axonal preservation, such threshold dosage effects might explain the variable expressivity and incomplete penetrance of SPG4-linked AD-HSP.
Similar articles
-
Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia.Hum Mol Genet. 2000 Mar 1;9(4):637-44. doi: 10.1093/hmg/9.4.637. Hum Mol Genet. 2000. PMID: 10699187
-
Mutation analysis of the spastin gene (SPG4) in patients in Germany with autosomal dominant hereditary spastic paraplegia.Hum Mutat. 2002 Aug;20(2):127-32. doi: 10.1002/humu.10105. Hum Mutat. 2002. PMID: 12124993
-
Three novel spastin (SPG4) mutations in families with autosomal dominant hereditary spastic paraplegia.J Neurol Sci. 2002 Sep 15;201(1-2):65-9. doi: 10.1016/s0022-510x(02)00192-2. J Neurol Sci. 2002. PMID: 12163196
-
Autosomal dominant spastic paraplegias: a review of 89 families resulting from a portuguese survey.JAMA Neurol. 2013 Apr;70(4):481-7. doi: 10.1001/jamaneurol.2013.1956. JAMA Neurol. 2013. PMID: 23400676 Review.
-
[AAA ATPases and hereditary spastic paraplegia].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009 Jun;26(3):298-301. doi: 10.3760/cma.j.issn.1003-9406.2009.03.013. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009. PMID: 19504443 Review. Chinese.
Cited by
-
Transcriptional and post-transcriptional regulation of SPAST, the gene most frequently mutated in hereditary spastic paraplegia.PLoS One. 2012;7(5):e36505. doi: 10.1371/journal.pone.0036505. Epub 2012 May 4. PLoS One. 2012. PMID: 22574173 Free PMC article.
-
A novel SPAST gene mutation identified in a Chinese family with hereditary spastic paraplegia.BMC Med Genet. 2020 Jun 3;21(1):123. doi: 10.1186/s12881-020-01053-7. BMC Med Genet. 2020. PMID: 32493220 Free PMC article.
-
Pathogenic mutation of spastin has gain-of-function effects on microtubule dynamics.J Neurosci. 2014 Jan 29;34(5):1856-67. doi: 10.1523/JNEUROSCI.3309-13.2014. J Neurosci. 2014. PMID: 24478365 Free PMC article.
-
Mechanistic basis of an epistatic interaction reducing age at onset in hereditary spastic paraplegia.Brain. 2018 May 1;141(5):1286-1299. doi: 10.1093/brain/awy034. Brain. 2018. PMID: 29481671 Free PMC article.
-
Modeling gain-of-function and loss-of-function components of SPAST-based hereditary spastic paraplegia using transgenic mice.Hum Mol Genet. 2022 Jun 4;31(11):1844-1859. doi: 10.1093/hmg/ddab367. Hum Mol Genet. 2022. PMID: 34935948 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
